medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2007, Number 6

<< Back Next >>

Rev Invest Clin 2007; 59 (6)

Endoscopic treatment of high-risk bleeding ulcers: success, rebleeding and mortality

Téllez-Ávila FI, Chávez-Tapia NC, Franco-Guzmán AM, Duarte-Rojo A, López-Arce G, Camacho JA, Ramírez-Luna MÁ

Language: English
References: 12
Page: 419-423
PDF size: 60.54 Kb.


ABSTRACT

Introduction and aims. Endoscopic treatment of peptic ulcers with high-risk stigmata has been probed. The rates of recurrent bleeding, need for emergent surgery and death are related to Forrest Classification, Blatchford’s modified risk score and the kind of endoscopic treatment used (monotherapy vs. dual). The aims of the present study were to report the success of endoscopic therapy in the reduction of the rate of initial success, recurrent bleeding, the need for surgery, and the mortality rate for patients with bleeding peptic ulcer and high-risk stigmata. Patients and methods. From a retrospective view, patients seen from September 2004 to March 2007 who had peptic ulcers Forrest Ia, Ib, IIa and/or IIb were included. Results. Fifty-six patients were included (mean [SD] age 57.3 ± 16.6 years). The success rate was 91%, whilst the rest of the patients required immediate surgery. Recurrent bleeding was presented in 14 (27%) patients and eight (14.2%) required emergency surgery. The mortality rate was 3.6%. No factors were associated with the risk of failure to initial treatment, recurrent bleeding or need for surgery. The use of monotherapy by endoscopy was associated with the mortality. The variable “fellow alone” was not associated with any kind of outcome. Conclusion. Complication rate is similar to previous reports of general hospitals, but is higher than those of referral centers. Endoscopic monotherapy is associated with a major mortality risk.


REFERENCES

  1. Cook DJ, Guyatt GH, Salena BJ, et al. Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhage: A metaanalysis. Gastroenterology 1992; 102: 139-48.

  2. Bardou M, Youssef M, Toubouti Y, et al. Newer Endoscopic therapies decrease both re-bleeding and mortality in high risk patients with acute peptic ulcer bleeding: A series of meta-analyses. Gastroenterology 2003; 123: A239 [abstract].

  3. 3 . Barkun A, Bardou M, Marshall JK, Nonvariceal Upper GI Bleeding Consensus Conference Group. Consensus recommendations for managing patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med 2003; 139: 843-57.

  4. Barkun AN, Chiba N, Enns R, Marshall J, Armstrong D, Sabbah S, et al. Use of a national endoscopic database to determine the adoption of emerging pharmacological and endoscopic technologies in the everyday care of patients with upper GI bleeding: the RUGBE initiative. Am J Gastroenterol 2001; 96: S261.

  5. Marmo R, Rotondano G, Piscopo R, et al. Dual therapy versus monotherapy in the endoscopic treatment of high-risk bleeding ulcers: a meta-analysis of controlled trials. Am J Gastroenterol 2007; 102(2): 279-89.

  6. Forrest JAH, Finlayson NDC, Shearman DJC. Endoscopy in gastrointestinal bleeding. Lancet 1974; 2: 394-7.

  7. Romagnuolo J, Barkun A, Enns R, Armstrong D, Gregor J, Registry for upper GI Bleeding and Endoscopy Investigator Group. Simple clinical predictors may obviate urgent endoscopy in selected patients with nonvariceal upper gastrointestinal tract bleeding. Arch Intern Med 2007; 167: 265-70.

  8. Calvet X, Vergara M, Brullet E, Gisbert J, Campo R. Addition of a second endoscopic treatment following epinephrine injection improves outcome in high-risk bleeding ulcers. Gastroenterology 2004; 126(2): 441-50.

  9. Chung SS, Lau JY, Sung JJ, Chan AC, Lai CW, Ng EK, et al. Randomized comparison between adrenaline injection alone and adrenaline injection plus heat probe treatment for actively bleeding ulcers. BMJ 1997; 314(7090): 1307-11.

  10. Chua TS, Fock KM, Ng TM, et al. Epinephrine injection therapy versus a combination of epinephrine injection and endoscopic hemoclip in the treatment of bleeding ulcers. World J Gastroenterol 2005; 11: 1044-7.

  11. Torres J, Leal-Herrera Y, Perez-Perez G, Gomez A, Camorlinga- Ponce, et al. A community-based seroepidemiologic study of Helicobacter pylori infection in Mexico. J Infect Dis 1998; 178(4): 1089-94.

  12. Zapata-Colindres JC, Zepeda-Gomez S, Montano-Loza A, et al. The association of Helicobacter pylori infection and nonsteroidal anti-inflammatory drugs in peptic ulcer disease. Can J Gastroenterol 2006; 20(4): 277-80.




2020     |     www.medigraphic.com